Bayer Investor News | Bayer Global

Stay informed about key developments at our company as they happen. Discover our Ad-Hoc Releases and subscribe to our newsletter to receive the latest news and topics of interest.

91 - 100of 412 News

91 - 100of 412 News

March 01, 2023

Not intended for U.S. and UK Media

Bayer submits aflibercept 8 mg for marketing authorization in Japan

February 28, 2023

Fiscal 2022

Bayer: Significant growth in sales and earnings

February 27, 2023

Not intended for U.S. and UK Media

Nubeqa™ approved for additional indication in Japan

February 10, 2023

Not intended for U.S. and UK Media

Kerendia™ (finerenone) granted expanded indication in the EU for broad range of patients with chronic kidney disease and type 2 diabetes

February 08, 2023

Bill Anderson to become CEO of Bayer AG

February 06, 2023

Not intended for U.S. and UK Media

Bayer submits aflibercept 8 mg for regulatory approval in two major retinal eye diseases in the EU

February 02, 2023

Bayer and Kimitec join forces to bring the next generation of Biologicals to millions of growers worldwide

January 31, 2023

Bayer to distribute pheromone-based biological crop protection solutions from M2i Group

January 27, 2023

Not intended for U.S. and UK Media

CHMP recommends Bayer’s darolutamide for the treatment of metastatic hormone-sensitive prostate cancer

January 19, 2023

Bayer launches new collaboration with Oerth Bio to further advance innovations in crop protection

Inform Yourself on Special Topics

Control Weeds Not Farming

Control Weeds, Not Farming

Farmers discussing their weed management

Everything You Need to Know About Glyphosate

some-bayer-group-headquarters

Managing Glyphosate Litigation

woman harvesting carrots

Managing and Mitigating PCB Litigation Risk